IBDEI04R ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1957,2)
 ;;=^295216
 ;;^UTILITY(U,$J,358.3,1958,0)
 ;;=V10.3^^21^187^4
 ;;^UTILITY(U,$J,358.3,1958,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1958,1,4,0)
 ;;=4^V10.3
 ;;^UTILITY(U,$J,358.3,1958,1,5,0)
 ;;=5^HX OF BREAST MALIGNANCY
 ;;^UTILITY(U,$J,358.3,1958,2)
 ;;=^295217
 ;;^UTILITY(U,$J,358.3,1959,0)
 ;;=V10.40^^21^187^27
 ;;^UTILITY(U,$J,358.3,1959,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1959,1,4,0)
 ;;=4^V10.40
 ;;^UTILITY(U,$J,358.3,1959,1,5,0)
 ;;=5^HX-FEMALE GENIT MALG NOS
 ;;^UTILITY(U,$J,358.3,1959,2)
 ;;=^295218
 ;;^UTILITY(U,$J,358.3,1960,0)
 ;;=V10.41^^21^187^23
 ;;^UTILITY(U,$J,358.3,1960,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1960,1,4,0)
 ;;=4^V10.41
 ;;^UTILITY(U,$J,358.3,1960,1,5,0)
 ;;=5^HX-CERVICAL MALIGNANCY
 ;;^UTILITY(U,$J,358.3,1960,2)
 ;;=^295219
 ;;^UTILITY(U,$J,358.3,1961,0)
 ;;=V10.42^^21^187^47
 ;;^UTILITY(U,$J,358.3,1961,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1961,1,4,0)
 ;;=4^V10.42
 ;;^UTILITY(U,$J,358.3,1961,1,5,0)
 ;;=5^HX-UTERUS MALIGNANCY NEC
 ;;^UTILITY(U,$J,358.3,1961,2)
 ;;=^295220
 ;;^UTILITY(U,$J,358.3,1962,0)
 ;;=V10.43^^21^187^19
 ;;^UTILITY(U,$J,358.3,1962,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1962,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,1962,1,5,0)
 ;;=5^HX OF OVARIAN MALIGNANCY
 ;;^UTILITY(U,$J,358.3,1962,2)
 ;;=^295221
 ;;^UTILITY(U,$J,358.3,1963,0)
 ;;=V10.44^^21^187^26
 ;;^UTILITY(U,$J,358.3,1963,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1963,1,4,0)
 ;;=4^V10.44
 ;;^UTILITY(U,$J,358.3,1963,1,5,0)
 ;;=5^HX-FEMALE GENIT MALG NEC
 ;;^UTILITY(U,$J,358.3,1963,2)
 ;;=^295222
 ;;^UTILITY(U,$J,358.3,1964,0)
 ;;=V10.45^^21^187^34
 ;;^UTILITY(U,$J,358.3,1964,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1964,1,4,0)
 ;;=4^V10.45
 ;;^UTILITY(U,$J,358.3,1964,1,5,0)
 ;;=5^HX-MALE GENIT MALIG NOS
 ;;^UTILITY(U,$J,358.3,1964,2)
 ;;=^295223
 ;;^UTILITY(U,$J,358.3,1965,0)
 ;;=V10.46^^21^187^39
 ;;^UTILITY(U,$J,358.3,1965,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1965,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,1965,1,5,0)
 ;;=5^HX-PROSTATIC MALIGNANCY
 ;;^UTILITY(U,$J,358.3,1965,2)
 ;;=^295224
 ;;^UTILITY(U,$J,358.3,1966,0)
 ;;=V10.47^^21^187^43
 ;;^UTILITY(U,$J,358.3,1966,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1966,1,4,0)
 ;;=4^V10.47
 ;;^UTILITY(U,$J,358.3,1966,1,5,0)
 ;;=5^HX-TESTICULAR MALIGNANCY
 ;;^UTILITY(U,$J,358.3,1966,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,1967,0)
 ;;=V10.48^^21^187^48
 ;;^UTILITY(U,$J,358.3,1967,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1967,1,4,0)
 ;;=4^V10.48
 ;;^UTILITY(U,$J,358.3,1967,1,5,0)
 ;;=5^PSNL HX MAL NEOPL-EPIDID
 ;;^UTILITY(U,$J,358.3,1967,2)
 ;;=^321226
 ;;^UTILITY(U,$J,358.3,1968,0)
 ;;=V10.49^^21^187^33
 ;;^UTILITY(U,$J,358.3,1968,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1968,1,4,0)
 ;;=4^V10.49
 ;;^UTILITY(U,$J,358.3,1968,1,5,0)
 ;;=5^HX-MALE GENIT MALIG NEC
 ;;^UTILITY(U,$J,358.3,1968,2)
 ;;=^295226
 ;;^UTILITY(U,$J,358.3,1969,0)
 ;;=V10.50^^21^187^46
 ;;^UTILITY(U,$J,358.3,1969,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1969,1,4,0)
 ;;=4^V10.50
 ;;^UTILITY(U,$J,358.3,1969,1,5,0)
 ;;=5^HX-URINARY MALIGNAN NOS
 ;;^UTILITY(U,$J,358.3,1969,2)
 ;;=^295227
 ;;^UTILITY(U,$J,358.3,1970,0)
 ;;=V10.51^^21^187^1
 ;;^UTILITY(U,$J,358.3,1970,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1970,1,4,0)
 ;;=4^V10.51
 ;;^UTILITY(U,$J,358.3,1970,1,5,0)
 ;;=5^HX OF BLADDER MALIGNANCY
 ;;^UTILITY(U,$J,358.3,1970,2)
 ;;=^295228
 ;;^UTILITY(U,$J,358.3,1971,0)
 ;;=V10.52^^21^187^10
 ;;^UTILITY(U,$J,358.3,1971,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1971,1,4,0)
 ;;=4^V10.52
